Cargando…

Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics

Detalles Bibliográficos
Autores principales:	Arlett, Peter, Straus, Sabine, Rasi, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977396/ https://www.ncbi.nlm.nih.gov/pubmed/31758540 http://dx.doi.org/10.1002/cpt.1689

Ejemplares similares

Response to "Pharmacovigilance 2030: Invited Commentary for the January 2020 ‘Futures’ Edition"
por: Hauben, Manfred, et al.
Publicado: (2020)

The World Health Organization Prequalification Program and Clinical Pharmacology in 2030
por: Blaschke, Terrence F., et al.
Publicado: (2019)

Invited Commentary
por: Gaber, A Osama
Publicado: (2021)

Invited Commentary
por: Weir, William, et al.
Publicado: (2021)

Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
por: Lu, Zhengwu
Publicado: (2009)

Invited Perspective: Metals, Micronutrients, and Mixtures—Future Directions
por: Claus Henn, Birgit
Publicado: (2023)

Treatment of the hypertensive patient in 2030
por: Bhudia, Roshni P.
Publicado: (2020)

Pharmacovigilance
por: Griffin, J. P.
Publicado: (1992)

Hypertension management in 2030: a kaleidoscopic view
por: Kulkarni, Spoorthy
Publicado: (2020)

Healthcare Management and the Humanities: An Invitation to Dialogue
por: Gerard, Nathan
Publicado: (2021)

Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone
por: Falzon, Dennis, et al.
Publicado: (2014)

Postmarketing pharmacovigilance: Remdesivir and cardiovascular events
por: Sullivan, John T.
Publicado: (2022)

Genome Editing: Past, Present, and Future 
por: Carroll, Dana
Publicado: (2017)

Implementation of a broad public health approach to COVID-19 in Sweden, January 2020 to May 2022
por: Tegnell, Anders, et al.
Publicado: (2023)

Invited Commentary: Stress and Mortality
por: Hotopf, Matthew, et al.
Publicado: (2008)

Commentary: January 21, 2020: The beginning of the end or the end of the beginning?
por: Hicks, George L.
Publicado: (2021)

A threefold approach to rescue the 2030 Agenda from failing
por: Pradhan, Prajal
Publicado: (2023)

Invited Perspective: Metals and Menarche
por: Pollack, Anna Z., et al.
Publicado: (2023)

Universal health coverage and primary health care: the 30 by 2030 campaign
por: De Maeseneer, Jan, et al.
Publicado: (2020)

Integrating science to address food and health within Global Agenda 2030
por: McBean, Gordon A.
Publicado: (2021)

Invite your representative to work. Change the world. Here’s how.
por: Montell, Denise J.
Publicado: (2018)

Invited commentary on GETUG-AFU 16
por: Lee, W. Robert
Publicado: (2016)

The Unexpected Hand Patient: Invited Commentary
por: Katzman, Stephen R.
Publicado: (2017)

Invited commentary on David Fedson’s article
por: Clark, Ian, et al.
Publicado: (2009)

The Chernobyl Disaster and Beyond: Implications of the Sendai Framework for Disaster Risk Reduction 2015–2030
por: Aitsi-Selmi, Amina, et al.
Publicado: (2016)

Ending AIDS as a public health threat by 2030: Time to reset targets for 2025
por: De Lay, Paul R., et al.
Publicado: (2021)

Pharmacological management of portal hypertension: current status and future
por: Gao, Zhu-Qing, et al.
Publicado: (2020)

A 2030 Vision for the Mayo Clinic Department of Medicine
por: Caine, Natalie A., et al.
Publicado: (2022)

The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level
por: Maure, Christine G, et al.
Publicado: (2014)

Safety of Germline Genome Editing for Genetically Related “Future” Children as Perceived by Parents
por: Ishii, Tetsuya, et al.
Publicado: (2019)

Invited Perspective: Inroads to Biology-Informed Exposomics
por: Vermeulen, Roel
Publicado: (2022)

Invited Perspective: Mixtures—Are They Worth the Risk (Assessment)?
por: Quiros-Alcala, Lesliam, et al.
Publicado: (2023)

Invited Perspective: Challenging the Dogma of Lead Neurotoxicity
por: Guilarte, Tomás R.
Publicado: (2023)

Invited Perspective: Air Pollution and Congenital Heart Defects (CHDs)—a Summary of Two Decades and Future Direction in Research
por: Agay-Shay, Keren
Publicado: (2023)

The American Society for Clinical Pharmacology and Therapeutics (ASCPT) ‐ A Rich Heritage En Route to an Exciting Future
por: Rocci, ML
Publicado: (2016)

An invited commentary on “The Surgeon and the COVID-19 pandemic”
por: Choudhury, Ehsanul Karim, et al.
Publicado: (2020)

Governing Heritable Human Genome Editing: A Textual History and a Proposal for the Future
por: Walters, LeRoy, et al.
Publicado: (2021)

Open Clinical Trial Data for All? A View from Regulators
por: Eichler, Hans-Georg, et al.
Publicado: (2012)

Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future
por: Chowdhury, Devyani, et al.
Publicado: (2021)

Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
por: Cave, Alison, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dvhk1nuqmdthtv5io2u2fvr7b7